AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04140422 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Application of one preservative-free lubricating eye drop, when waking up and one eye drop 30 min later to the fellow eye by the investigators
Study NCT03427957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Endometrial biopsy with the new hysteroscopic grasper with knurled terminal end and cutting jaws
Description: Hysteroscopic endometrial biopsy performed through the new grasper with knurled terminal end and cutting jaws.
Study NCT03427957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Endometrial biopsy with the hysteroscopic spoon grasper
Description: Hysteroscopic endometrial biopsy performed through the spoon grasper.
Study NCT03427957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Endometrial biopsy with the hysteroscopic alligator grasper
Description: Hysteroscopic endometrial biopsy performed through the alligator grasper.
Study NCT00796237 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole body vibration therapy
Description: In their regular physiotherapy sessions, the subjects in the experimental group will receive WBV (20-240Hz, 10-minute sessions, 1 session per day, 5 sessions per week). The vibration loading will be carried out using the Fit-Vibe System (Germany), which is a vibration platform that is capable of generating vertical vibration.
Study NCT00796237 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standing on the vibration platform but no vibration will be applied
Description: The subjects in this group will perform the same exercises on the vibration platform as in the experimental group for the same duration, but no vibration will be given.
Study NCT02231320 — intervention group
Intervention type: DRUG
Intervention: Berodual® Respimat® - inhaler
Study NCT04784481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: Experimental Group received Ivermectin orally 4 tablets of 6 mg = 24 mg every 7 days for 4 weeks.
Study NCT02056899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Study NCT00279942 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Soy
Description: Drink a shake (vanilla and chocolate taste) once a day for 6 weeks.
Study NCT00279942 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Drink a shake (vanilla and chocolate taste) once a day for 6 weeks.
Study NCT03826381 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic resonance (MR) spectroscopy of the liver
Description: Magnetic resonance (MR) spectroscopy of the liver. Golden standard for non-invasive determination of NAFLD
Study NCT03826381 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Fibroscan
Description: Transient Elastography for Measurement of liver fibrosis.
Study NCT03826381 — intervention group
Intervention type: DEVICE
Intervention: Continuous glucose monitoring (CGM) for four days.
Description: CGM is attached to the abdominal skin for four days. Afterwards data is converted and analysed in a computer program.
Study NCT03826381 — intervention group
Intervention type: RADIATION
Intervention: Dual Energy X-ray Absorptiometry (DEXA) scan
Description: DEXA-scan of the body composition.
Study NCT03826381 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood samples
Description: Immediately analyse of basic lab data. Later analyses for glucagon, amino acids, bile acids, lipidomics and metabolomics.
Study NCT03826381 — intervention group
Intervention type: OTHER
Intervention: Clinical and demographic data
Description: Measurements of blood pressure, pulse, height, weight.
Study NCT00692926 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: ALDHbr Umbilical Cord Blood Cells
Description: ALDHbr sorted Umbilical Cord Blood Cells
Study NCT00152321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patients (education, counseling) and Physicians (reminders,1-page guidelines).
Study NCT00152321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Description: Educational materials, counseling, opinion leader based guidelines, reminders
Study NCT00152321 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Study NCT04066179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gcsf
Description: Granulocytes-Colony Stimulating Factor 300 mcg for 7 days followed by 300 mcg every 3 days
Study NCT04066179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: Prednisolone 40 mg for initial 7 days
Study NCT04066179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Prednisolone 40 mg for initial 7 days
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical anti-infective therapy
Description: Two months before randomization, implants with peri-implantitis received surgical anti-infective therapy. After local anesthesia (2% lidocaine with 1:100,000 epinephrine), intrasulcular incisions were done and buccal and lingual full-thickness flaps were dissected. Granulation tissue was removed to expose the implant threads and bone defect. To remove biofilm and calculus, the implant surface was scaled with teflon curettes and decontaminated with bicarbonate jet (Jet Sonic System). The flap was repositioned in the original position and stabilized with interrupted sutures, which were removed after 10 days
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical anti-infective therapy
Description: Two months before randomization, implants with peri-implantitis received surgical anti-infective therapy. After local anesthesia (2% lidocaine with 1:100,000 epinephrine), intrasulcular incisions were done and buccal and lingual full-thickness flaps were dissected. Granulation tissue was removed to expose the implant threads and bone defect. To remove biofilm and calculus, the implant surface was scaled with teflon curettes and decontaminated with bicarbonate jet (Jet Sonic System). The flap was repositioned in the original position and stabilized with interrupted sutures, which were removed after 10 days
Study NCT01168492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ketamine
Description: 0.5mg/kg ketamine iv
Study NCT01168492 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ketamine
Description: 0.5mg/kg ketamine iv
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BMI screening
Description: Physician screening of patients to identify patients who are overweight or obese.
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BMI screening
Description: Physician screening of patients to identify patients who are overweight or obese.
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Next Steps brief clinical intervention
Description: This intervention included identification of children who were overweight or obese, and Next Steps brief counseling materials for the healthcare provider (prior to enrollment in the intervention).
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Next Steps brief clinical intervention
Description: This intervention included identification of children who were overweight or obese, and Next Steps brief counseling materials for the healthcare provider (prior to enrollment in the intervention).
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MEND/CATCH
Description: MEND 2-5 and MEND/CATCH 6-12 programs are multi-component interventions including behavioral, nutrition, and physical activity sessions. In the intensive (first 3 months) phase, MEND 2-5 entailed nine weekly sessions and MEND 6-12 entailed 18 twice weekly sessions.
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MEND/CATCH Transition Phase
Description: The transition phase (next 9 months of the 12-month program) included monthly 90-minute sessions for parents and children included MEND reviews, cooking classes, Being Well book, CATCH activities and MEND World activities. Children were enrolled in YMCA sports teams or programs offered twice weekly to encourage physical activity. Weekly text messages were sent to parents to reinforce behavioral objectives of the intervention.
Study NCT02724943 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Next Steps Self-Paced Booklet
Description: Next Steps booklet for parents and children to work on nutrition and physical activity targets in a self-directed manner. Families were encouraged to seek repeated clinical visits to address child obesity as a follow up to the self-paced booklet.
Study NCT01087008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zoledronic acid
Description: Zoledronic acid 4 mg every 4 weeks for a total of 12 treatments
Study NCT01087008 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No treatment control
Description: Patients doesn't receive treatment
Study NCT03234426 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Perturbation
Description: Manual perturbations were given at waist region,over the Shoulders. in following positions- sitting, kneeling, standing positions,10 perturbations were given in forward,backward,both right and left side, 6 days in a week all precautionary measures taken for the patient's safety
Study NCT03234426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perturbation
Description: Manual perturbations were given at waist region,over the Shoulders. in following positions- sitting, kneeling, standing positions,10 perturbations were given in forward,backward,both right and left side, 6 days in a week all precautionary measures taken for the patient's safety
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Periodontal treatment
Description: Two months before randomization, all subjects received full-mouth supragingival plaque removal and scaling and root planing (SRP), as needed. The SRP was performed in four to six appointments lasting approximately 1 h each, using manual curettes (Hu-Friedy, Chicago, IL, USA) and ultrasonic device (Cavitron Select SPC, Dentsply professional, York, PA, USA) under local anesthesia. The deep sites were scaled throughout the first week and treatment of the entire oral cavity was completed in 14 days.
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Description: Two months before randomization, all subjects received full-mouth supragingival plaque removal and scaling and root planing (SRP), as needed. The SRP was performed in four to six appointments lasting approximately 1 h each, using manual curettes (Hu-Friedy, Chicago, IL, USA) and ultrasonic device (Cavitron Select SPC, Dentsply professional, York, PA, USA) under local anesthesia. The deep sites were scaled throughout the first week and treatment of the entire oral cavity was completed in 14 days.
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Oral Hygiene Instruction
Description: Delivery of a soft bristle adult toothbrush (Colgate Palmolive, Brazil), dental floss (Colgate Palmolive, Brazil), and interdental toothbrushes (Colgate Palmolive, Brazil) , according to their individual needs at pre-baseline, baseline, 3, 6, 12, 18 and 24 months. Information was given about the importance of keeping an excellent oral hygiene over the course of the study. The subjects were instructed to brush their teeth for one minute twice a day (morning and evening) using only the toothbrush and toothpaste provided.
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral Hygiene Instruction
Description: Delivery of a soft bristle adult toothbrush (Colgate Palmolive, Brazil), dental floss (Colgate Palmolive, Brazil), and interdental toothbrushes (Colgate Palmolive, Brazil) , according to their individual needs at pre-baseline, baseline, 3, 6, 12, 18 and 24 months. Information was given about the importance of keeping an excellent oral hygiene over the course of the study. The subjects were instructed to brush their teeth for one minute twice a day (morning and evening) using only the toothbrush and toothpaste provided.
Study NCT03191721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triclosan toothpaste
Description: Dental brushing with a toothpaste containing 0.3% triclosan and 1450 ppm sodium fluoride in a regular maintenance program for 24 months.
Study NCT03191721 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluoride toothpaste
Description: Dental brushing with a toothpaste containing 1450 ppm sodium monofluorphosphate in a regular maintenance program for 24 months.
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Regular maintenance program
Description: OHI, supragingival and subgingival biofilm removal from teeth and implants, and oral prophylaxis. If the examiner suspected of peri-implant disease progression, periapical radiographs were taken. If the implant showed ≥ 2 mm of bone loss, it was withdrawn from the study to receive additional treatment (e.g. another surgery procedure). Implants showing severe disease progression associated with mobility were removed. Maintenance visits were performed every 3 months.
Study NCT03191721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regular maintenance program
Description: OHI, supragingival and subgingival biofilm removal from teeth and implants, and oral prophylaxis. If the examiner suspected of peri-implant disease progression, periapical radiographs were taken. If the implant showed ≥ 2 mm of bone loss, it was withdrawn from the study to receive additional treatment (e.g. another surgery procedure). Implants showing severe disease progression associated with mobility were removed. Maintenance visits were performed every 3 months.
Study NCT00402688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levofloxacin
Description: 750mg tablet once daily for 2 weeks followed by 2 weeks of placebo.
Study NCT00402688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levofloxacin
Description: 750mg tablet once daily for 3 weeks followed by 1 week of placebo.
Study NCT00402688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levofloxacin
Description: 500mg tablet once daily for 4 weeks.
Study NCT01427647 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic technique and thoracic epidural anesthesia
Description: We have compared colorectal cancer surgery under two types of surgical(laparoscopic versus open) and anesthesia (thoracic epidural versus general) techniques
Study NCT03027570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control
Description: Five-month interdisciplinary program, including: twice a week one-hour group exercise activity sessions, 3-5 group meetings with a dietician, 12-13 parent sessions with a social worker, and a healthy cooking workshop, each child will take part in individual sessions including: two appointments with a pediatrician, three sessions with a dietician and two sessions with a physical therapist serving as a consultant for physical activity.
Study NCT03027570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exergame activity_EXG
Description: In addition to the treatment given to the control group (as described above), the EXG group will obtain home access to the app Just Dance Now and part of a weekly exercise session will include a group activity with the app.
Study NCT03027570 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application activity
Description: The application - Just Dance Now will be downloaded to the cellular phone of the child or parent. Exercise using the app will be used by cell phone connection to the child's home computer and as part of exercise group activity.
Study NCT00767325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Description: Abatacept, 10 mg/kg, solution given intravenously on Days 1, 15, 29,57, 85, 113, 141, and 169
Study NCT02084043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebulization of Amikacin during NIV (RR: 15 cycles/minute)
Description: 500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds. The NIV is set with an IPAP of 15 cmH2O and EPAP of 5 cmH2O. The lung model is simulated with a respiratory rate of 15 cycles/minute
Study NCT00767325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Methotrexate administered in a dose of 15 mg/week or higher for at least 3 months and at a stable dose for at least 28 days prior to baseline
Study NCT03982758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: isometric handgrip exercise
Description: Isometric session with handgrip: 4 sets of 2 minutes of contractions sustained at 30% of CVM, for each arm. The time between sets and between arms will be 1 minute rest.
Study NCT03982758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: isometric of the lower limbs
Description: Isometric session for lower limbs: 4 sets with 2 minutes of contractions sustained at 30% of 1RM. The rest interval will be 1 minute rest.
Study NCT01983956 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SENS model
Description: Palliative care with a structured approach (SENS model) based on the bio-psycho-social-spiritual model of care, the WHO definitions of palliative care as well as the National Comprehensive Cancer Networks (NCCN) Practice Guidelines for Palliative Care. The approach supports the assessment of areas and complexity of concerns from the patient perspective, determines the priority and structures the support needed. The intervention is performed by palliative care physicians and nurses collaboratively. It is utilized as baseline assessment and afterwards integrated in each routine oncology care out-patient and in-patient visit. Depending on the goals it may be applied between routine visits. In addition, patients will receive usual oncology care throughout the study period.
Study NCT00746668 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Module 1: Visual Awareness and Eccentric Viewing
Description: In this module, awareness of the PRL location and eccentric viewing were trained. Exercises based on published sources were administered. One example of these exercises is the clock face display adapted from Holcomb and Goodrich and Maplesden.~This module also focused on awareness of the perceptual consequences of using a PRL. The purpose of these training exercises was to allow the subjects to appreciate perceptual alterations that occur when using a PRL and to practice making perceptual discriminations with the peripheral retina. Previously published work has demonstrated that perception in the peripheral retina can be affected by practice.
Study NCT03234426 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional Physiotherapy Treatment
Description: Conventional Physiotherapy treatment were given to participants included in this group for 30 mins daily for 4 weeks
Study NCT03234426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy Treatment
Description: Conventional Physiotherapy treatment were given to participants included in this group for 30 mins daily for 4 weeks
Study NCT00746668 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Module 2: Control of Reading Eye Movements
Description: In this module, control of eye movements was trained. These exercises began with a series of saccade tasks to nonalphabetical stimuli and then progressed to single letter, letter pairs, and word stimuli. Subjects were instructed to make a saccade between the dots. The experimenter provided feedback concerning the appropriateness of the saccades, and the alternation rate of the dots was increased as performance improved.
Study NCT00746668 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Module 3: Reading Practice with RSVP
Description: In module 3, we wanted to assess only the higher-level effects of reading practice. Subjects practiced reading using stimuli that did not require reading eye movements. An example is short sentences that were presented one word at a time at a single location on a screen (Rapid Serial Visual Presentation \[RSVP\]). At the end of the sentence, subjects reported whether the sentence made sense or not. We also had our subjects practice reading scrolled text. Although, eye movements and saccades may spontaneously occur under the text presentation conditions of this module, they are not the efficient saccades necessary for reading.
Study NCT02084043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebulization of Amikacin during NIV (RR: 25 cycles/minute)
Description: 500 mg/4 mL Amikacin nebulized using vibrating mesh nebulizer associated with a single limb bilevel ventilator. The nebulizations are considered as finished when there is no visible evidence of nebulization for a period of 30 seconds. The NIV is set with an IPAP of 15 cmH2O and EPAP of 5 cmH2O. The lung model is simulated with a respiratory rate of 25 cycles/minute
Study NCT04879186 — intervention group
Intervention type: PROCEDURE
Intervention: Peripheral endovascular angioplasty
Description: Peripheral endovascular angioplasty - using endovascular techniques to treat peripheral artery occlusive lesions.
Study NCT05333302 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD19 CAR-T-cells
Description: One dose of CD19 CAR-T cells (1\*10e6 CAR+ T-cells/kg) by intravenous infusion.
Study NCT05333302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Description: Before 1h of CAR-T cells infusion a patient receive tocilizumab (8 mg/kg).
Study NCT04572503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Barbed Suture Modified Anterior Palatoplasty
Description: Barbed Suture Modified Anterior Palatoplasty using single resorbable polydioxanone barbed bidirectional size 0 monofilament suture
Study NCT00679939 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosiglitazone
Description: up to 8mg/day